X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (345) 345
Publication (58) 58
Book / eBook (9) 9
Conference Proceeding (5) 5
Web Resource (2) 2
Book Chapter (1) 1
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (228) 228
female (163) 163
male (162) 162
middle aged (153) 153
adult (134) 134
index medicus (134) 134
hematology (127) 127
aged (106) 106
oncology (81) 81
treatment outcome (61) 61
adolescent (57) 57
chemotherapy (48) 48
antineoplastic combined chemotherapy protocols - therapeutic use (47) 47
aged, 80 and over (44) 44
transplantation (43) 43
therapy (42) 42
hematopoietic stem cell transplantation (39) 39
transplantation, autologous (35) 35
cancer (33) 33
disease-free survival (33) 33
young adult (33) 33
stem cells (31) 31
care and treatment (28) 28
survival (28) 28
prognosis (27) 27
research (27) 27
analysis (26) 26
transplantation, homologous (26) 26
antineoplastic agents - therapeutic use (25) 25
antineoplastic combined chemotherapy protocols - adverse effects (24) 24
follow-up studies (24) 24
retrospective studies (23) 23
health aspects (22) 22
recurrence (22) 22
chronic myelogenous leukemia (21) 21
gene expression (21) 21
genetic aspects (21) 21
leukemia (21) 21
combined modality therapy (20) 20
remission induction (20) 20
risk factors (20) 20
stem cell transplantation (20) 20
survival rate (20) 20
antineoplastic combined chemotherapy protocols - administration & dosage (19) 19
disease (19) 19
lymphomas (18) 18
rituximab (18) 18
patients (17) 17
abridged index medicus (16) 16
antineoplastic agents - administration & dosage (16) 16
child (16) 16
expression (16) 16
relapse (16) 16
stem-cell transplantation (16) 16
survival analysis (16) 16
time factors (16) 16
bone marrow (15) 15
cells (15) 15
cyclophosphamide - administration & dosage (15) 15
hematology, oncology and palliative medicine (15) 15
hodgkin disease - therapy (15) 15
neoplasm staging (15) 15
tumors (15) 15
follow-up (14) 14
genes (14) 14
risk (14) 14
biology (13) 13
bone marrow transplantation (13) 13
bone-marrow-transplantation (13) 13
cell biology (13) 13
child, preschool (13) 13
cyclophosphamide (13) 13
genetics (13) 13
hematopoietic stem cells (13) 13
italy (13) 13
medicine (13) 13
multiple myeloma - drug therapy (13) 13
mutation (13) 13
transplantation conditioning - methods (13) 13
acute myeloid leukemia (12) 12
chronic myeloid leukemia (12) 12
cytarabine - administration & dosage (12) 12
disease progression (12) 12
gene expression profiling (12) 12
leukemia, myelogenous, chronic, bcr-abl positive - therapy (12) 12
medical research (12) 12
multiple myeloma - mortality (12) 12
prednisone - administration & dosage (12) 12
remission (12) 12
research article (12) 12
thalidomide - administration & dosage (12) 12
trial (12) 12
vidarabine - analogs & derivatives (12) 12
blood (11) 11
bone-marrow transplantation (11) 11
development and progression (11) 11
doxorubicin - administration & dosage (11) 11
kaplan-meier estimate (11) 11
lymphoma (11) 11
medicine, research & experimental (11) 11
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Online Resources - Online (2) 2
Robarts - Stacks (2) 2
Credit Valley Hospital - Stacks (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2001, 1, ISBN 185317890X, xv, 528
In this volume, an international team of experts in chronic myeloid leukemia share their expertise. In particular, they contribute their insights on the latest... 
Treatment | Leukemia, Myeloid | Acute myeloid leukemia | therapy | Clinical & internal medicine | Acute myelocytic leukaemia | Hematology | Oncology | Acute myelocytic leukemia
Book
Journal Article
Current Cancer Drug Targets, ISSN 1568-0096, 09/2013, Volume 13, Issue 7, pp. 749 - 754
Tyrosin Kinase inhibitors (TKI), have dramatically changed the natural history of chronic myeloid leukemia (CML) leading to an impressive increase in overall... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2011, Volume 29, Issue 8, pp. 986 - 993
Purpose In patients with myeloma, thalidomide significantly improves outcomes but increases the risk of thromboembolic events. In this randomized, open-label,... 
LOW-DOSE WARFARIN | DEXAMETHASONE | THERAPY | VENOUS THROMBOEMBOLISM | ONCOLOGY | DEEP-VEIN THROMBOSIS | PREDNISONE PLUS THALIDOMIDE | BORTEZOMIB | STEM-CELL TRANSPLANTATION | ELDERLY-PATIENTS | MELPHALAN | Multiple Myeloma - mortality | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Warfarin - adverse effects | Male | Antineoplastic Agents - administration & dosage | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Warfarin - therapeutic use | Fibrinolytic Agents - adverse effects | Multiple Myeloma - drug therapy | Thromboembolism - prevention & control | Time Factors | Aspirin - adverse effects | Fibrinolytic Agents - therapeutic use | Cardiovascular Diseases - mortality | Female | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Cardiovascular Diseases - etiology | Risk Assessment | Multiple Myeloma - complications | Risk Factors | Anticoagulants - therapeutic use | Treatment Outcome | Thromboembolism - etiology | Thromboembolism - mortality | Thalidomide - administration & dosage | Anticoagulants - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Italy | Aged | Hemorrhage - chemically induced
Journal Article
1995, Clinical drug investigation, Volume 9, suppl. 2., 60
Book
PLoS ONE, ISSN 1932-6203, 03/2012, Volume 7, Issue 3, p. e33663
Journal Article
The Lancet, ISSN 0140-6736, 06/2002, Volume 359, Issue 9323, pp. 2065 - 2071
High-dose chemotherapy followed by transplantation of autologous haemopoietic stem cells (BEAMHSCT) is frequently used to treat patients with relapsed... 
SALVAGE CHEMOTHERAPY | ADULT PATIENTS | MEDICINE, GENERAL & INTERNAL | THERAPY | BONE-MARROW-TRANSPLANTATION | 1ST RELAPSE | COMBINATION CHEMOTHERAPY | REGIMEN | LYMPHOMA | CYTOREDUCTION | BLOOD | Recurrence | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Dexamethasone - adverse effects | Male | Cytarabine - adverse effects | Melphalan - therapeutic use | Cause of Death | Carmustine - therapeutic use | Melphalan - adverse effects | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Carmustine - adverse effects | Dexamethasone - administration & dosage | Etoposide - adverse effects | Hematopoietic Stem Cell Transplantation | Etoposide - administration & dosage | Etoposide - therapeutic use | Cytarabine - administration & dosage | Dexamethasone - therapeutic use | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Salvage Therapy - methods | Carmustine - administration & dosage | Evaluation | Chemotherapy | Transplantation | Hodgkin's disease | Hematopoietic stem cells | Lymphomas | Transplants & implants | Clinical outcomes | Stem cells | Dual energy X-ray absorptiometry | Autografts | Dexamethasone | Medical treatment | Etoposide | Stem cell transplantation | Infections | Patients | Blood | Abdomen | Randomization | Cytarabine | Biopsy | Medical prognosis | Failure analysis | Melphalan | Bone marrow | Remission | Stratigraphy
Journal Article
Haematologica, ISSN 0390-6078, 09/2013, Volume 98, Issue 9, pp. 1335 - 1343
Journal Article
Nature Genetics, ISSN 1061-4036, 01/2015, Volume 47, Issue 2, pp. 132 - 141
Journal Article
PloS one, ISSN 1932-6203, 2014, Volume 9, Issue 10, p. e108950
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2013, Volume 369, Issue 2, pp. 111 - 121
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2014, Volume 371, Issue 10, pp. 895 - 905
In patients 65 or younger with multiple myeloma, high-dose consolidation therapy was associated with longer survival and more myelotoxicity than... 
MEDICINE, GENERAL & INTERNAL | PREDNISONE | PLUS DEXAMETHASONE | INDUCTION THERAPY | LENALIDOMIDE | INITIAL TREATMENT | RANDOMIZED CONTROLLED-TRIAL | BORTEZOMIB | STEM-CELL TRANSPLANTATION | ELDERLY-PATIENTS | MELPHALAN | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Multiple Myeloma - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Transplantation, Autologous | Consolidation Chemotherapy | Antineoplastic Agents, Alkylating - administration & dosage | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Multiple Myeloma - therapy | Melphalan - adverse effects | Adult | Maintenance Chemotherapy | Neutropenia - chemically induced | Thalidomide - adverse effects | Prednisone - administration & dosage | Prednisone - adverse effects | Kaplan-Meier Estimate | Combined Modality Therapy | Thalidomide - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Aged | Antineoplastic Agents, Alkylating - adverse effects | Stem Cell Transplantation - adverse effects | Complications and side effects | Care and treatment | Patient outcomes | Multiple myeloma | Stem cells | Transplantation | Research | Health aspects | Autografts | Chemotherapy | Cell survival | Transplants & implants | Melphalan | Stem cell transplantation | Death | Prednisone | Drug dosages | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article